Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing Director Arvind
Categories
pharmaceuticals
Earnings | ALEMBIC PHARMACEUTICALS LIMITED (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1.3% YoY.
Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products,
Earnings | Ajanta Pharma Ltd. (NSE: AJANTAPHARMA): Q4FY23 Results Out; Total Income rises 2.1% YoY.
Ajanta Pharma is a leading Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of high-quality specialty pharmaceutical finished dosages.
Earnings | Aarti Drugs Ltd. (NSE: AARTIDRUGS): Q4FY23 Results Out; Total Income rise 8.5% YoY
Aarti Drugs Ltd. is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs), intermediates,
Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights
https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding non-ARV formulation
Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Transcript
Laurus Labs Limited (NSE:LAURUSLABS) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer V V
Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!
Stock Data: TickerNSE: BROOKS & BSE: 533543ExchangeNSE & BSEIndustryPHARMACEUTICALS & BIOTECHNOLOGY Price Performance: Last 5 Days-1.49%YTD-39.27%Last 12 Months-33.95% Company Description: Brooks Laboratories Ltd
Dr. Reddy’s Laboratories: One Of The Major Player In Generic Segment
“We are progressing well on our pipeline products. The number of filings in several of our key markets have been improving. The
Neuland Laboratories Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices are becoming
Sequent Scientific Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Management Update: [00:05:37] SEQUENT said that in the API business, the
Supriya Lifescience Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains on expanding
Orchid Pharma Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Q&A Highlights: [00:04:43] Himanshu Upadhyay from o3 Capital asked what changed
Earnings Summary Of Lupin Limited For Q3 FY23
Lupin Limited is a pharmaceutical company headquartered in Mumbai, India. The company was founded in 1968 and has operations in over 100
Earnings Summary Of Jubilant Pharmova Limited For Q3 FY23
Jubilant Pharmova Limited (NSE: JUBLPHARMA) was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in
Earnings | Dr. Reddy’s Laboratories Ltd. (NSE:DRREDDY): Q3FY23 Results Out; Total Income rise 27% YoY
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY) is a multinational pharmaceutical company based in Hyderabad, India. The company was founded in 1984 and has
Earnings Summary Of Jubilant Ingrevia Limited For Q3 FY23
Jubilant Ingrevia Limited (NSE: JUBLINGREA) is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the
Earnings Summary Of IPCA Laboratories Limited For Q3 FY23
Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription
Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry
Earnings Summary Of Indoco Remedies Limited For Q3 FY23
Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a
IPCA Laboratories Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:51] Kunal Dhamesha of Macquarie asked if IPCALAB is
Earnings Summary Of Glenmark Pharmaceuticals Limited For Q3 FY23
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) is a global research-driven pharmaceutical company that develops and markets innovative drugs for major therapeutic areas such